Homologous and heterologous prime boost vaccinations with distinct variants of Plasmodium vivax circumsporozoite protein (CSP) protects mice against transgenic PB/PV sporozoite challenge
Vaccine development against Plasmodium vivax malaria lags behind that for Plasmodium falciparum. To narrow this gap, we administered recombinant antigens based on P. vivax circumsporozoite protein (CSP) to mice.
Үндсэн зохиолчид: | Freitas, E, Camargo, T, Gimenez, A, Lima, L, Caramico, K, Francoso, K, Bruna-Romero, O, Ertl, H, Nussenzweig, R, Nussenzweig, V, Rodrigues, M, Reyes-Sandoval, A, Soares, I |
---|---|
Формат: | Conference item |
Хэвлэсэн: |
American Society of Tropical Medicine and Hygiene
2017
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge
-н: de Camargo, T, зэрэг
Хэвлэсэн: (2018) -
Vaccine containing the three allelic variants of the Plasmodium vivax circumsporozoite antigen induces protection in mice after challenge with a transgenic rodent Malaria parasite..
-н: Gimenez, A, зэрэг
Хэвлэсэн: (2017) -
Development of a sporozoite malaria vaccine
-н: Victor Nussenzweig, зэрэг
Хэвлэсэн: (1986-01-01) -
Vaccine Containing the Three Allelic Variants of the Plasmodium vivax Circumsporozoite Antigen Induces Protection in Mice after Challenge with a Transgenic Rodent Malaria Parasite
-н: Alba Marina Gimenez, зэрэг
Хэвлэсэн: (2017-10-01) -
T cell responses to repeat and non-repeat regions of the circumsporozoite protein detected in volunteers immunized with Plasmodium falciparum sporozoites
-н: Elizabeth Nardin, зэрэг
Хэвлэсэн: (1992-01-01)